2m 2m 2m 2m 2m 2m 2m
UNICYCIVE THERAP (UNCY)
NASDAQ
$5.32+$0.03 (+0.60%)
Price as of Sep 11, 2026 7:55 PM EDT- $147.4MMarket Cap
- 36.69%1-Year Change
- BiotechnologyIndustry
UNICYCIVE THERAP (UNCY)
$5.32+$0.03 (+0.60%)
UNCY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.29 | ||
Change | -$0.02 (-0.38%) | ||
Open | $5.34 | ||
High | $5.40 | ||
Low | $5.22 | ||
Previous Close | $5.31 | ||
Volume | 1,116,676 | ||
30-Day Average Volume | 796,774 | ||
1-Week Change | 2.52% | ||
1-Month Change | 5.80% | ||
1-Year Change | 36.69% | ||
3-Year Change | -26.12% | ||
5-Year Change | -81.95% | ||
Fundamentals | |||
Shares Outstanding | 27.9M | ||
Total Assets | $72.0M | ||
Market Cap | $147.4M | ||
Enterprise Value | $103.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$1.8M | ||
Free Cash Flow | -$7.6M | ||
EBIT | -$1.8M | ||
EBITDA | -$1.7M | ||
Net Working Capital | $52.6M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -59 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -88 | ||
PEG | -1 | ||
Price/Free Cash Flow | -19 | ||
Price/Operating Cash Flow | -19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 06/20/2025 | ||
Earnings & Revenue